In the last few decades, minimally-invasive technologies and techniques have changed the medical landscape. Today, doctors who perform cosmetic procedures have an increasingly sophisticated range of treatments at their disposal, which means that patients have greater possibilities to achieve their enhancement goals. For those wishing to combat the signs of aging, there is a novel treatment that may pave the way to better skin. Stem Cell Aesthetics is a revolutionary new therapy that can potentially help regenerate damaged skin.
Goldenberg Dermatology is pleased to announce that it is an exclusive dermatology partner of Predictive Biotech stem cell treatment, a cellular and regenerative medicine company. We are the first dermatology practice in New York City to offer the Stem Cell Aesthetics procedure.
Mesenchymal stem cells (MSCs) are stromal cells that have the capacity to develop into specialized cells in a process called cellular differentiation. MSCs are pluripotent, or able to become a range of cell types, including cells that produce collagen and support cells for skin inhancement.
During a Stem Cell Aesthetics procedure, MSCs are introduced into the treatment area when an stem cell suspension product in injected into the skin or applied to the skin after laser or microneeding treatment. The injection product contains growth factors and other cellular products, which are involved in the body’s regenerative functions.
A Stem Cell Aesthetics procedure takes about 30 minutes to complete and does not require surgery. The non-invasive treatment can:
A Stem Cell Aesthetics procedure can be combined with other non-surgical procedures to produce optimal results.
If you are interested in the latest advances in non-surgical facial rejuvenation, contact Goldenberg Dermatology in Manhattan to learn more about cutting-edge therapies. Dr. Gary Goldenberg and Dr. Kristina Goldenberg can recommend a customized plan to improve the texture and overall appearance of your skin.
Umbilical cord stem cells are obtained from C-section deliveries from normal, full-term pregnancies. Donors that consent to use of their birth tissues are carefully screened prior to the use of their tissues in manufacturing the product and all precautions are taken. The product is then screened again after the stem cells are extracted.